- Home
- SYRE vs FIGR Comparison
SYRE vs FIGR Comparison
Compare SYRE & FIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYRE | FIGR |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | United States |
| Employees | N/A | 602 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | FIGR |
|---|---|---|
| Price | $71.71 | $37.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $85.08 | $53.22 |
| AVG Volume (30 Days) | 1.3M | ★ 3.6M |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $69.23 |
| Revenue Next Year | N/A | $24.25 |
| P/E Ratio | ★ N/A | $134.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.29 | $25.01 |
| 52 Week High | $76.00 | $78.00 |
Technical Indicators
Market Signals| Indicator | SYRE | FIGR |
|---|---|---|
| Relative Strength Index (RSI) | 62.72 | 59.54 |
| Support Level | $30.39 | $36.68 |
| Resistance Level | $74.92 | $41.97 |
| Average True Range (ATR) | 4.18 | 2.19 |
| MACD | -0.78 | 0.38 |
| Stochastic Oscillator | 43.70 | 88.92 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About FIGR Figure Technology Solutions Inc.
Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.